157 related articles for article (PubMed ID: 23363058)
21. Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 Inhibitors.
Papillon JP; Adams CM; Hu QY; Lou C; Singh AK; Zhang C; Carvalho J; Rajan S; Amaral A; Beil ME; Fu F; Gangl E; Hu CW; Jeng AY; LaSala D; Liang G; Logman M; Maniara WM; Rigel DF; Smith SA; Ksander GM
J Med Chem; 2015 Jun; 58(11):4749-70. PubMed ID: 25953419
[TBL] [Abstract][Full Text] [Related]
22. Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase.
Stefanachi A; Hanke N; Pisani L; Leonetti F; Nicolotti O; Catto M; Cellamare S; Hartmann RW; Carotti A
Eur J Med Chem; 2015 Jan; 89():106-14. PubMed ID: 25462231
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
Ferlin MG; Carta D; Bortolozzi R; Ghodsi R; Chimento A; Pezzi V; Moro S; Hanke N; Hartmann RW; Basso G; Viola G
J Med Chem; 2013 Oct; 56(19):7536-51. PubMed ID: 24025069
[TBL] [Abstract][Full Text] [Related]
24. Targeting Steroidogenic Cytochromes P450 (CYPs) with 6-Substituted 1-Imidazolylmethylxanthones.
Gobbi S; Hu Q; Zimmer C; Belluti F; Rampa A; Hartmann RW; Bisi A
ChemMedChem; 2016 Aug; 11(16):1770-7. PubMed ID: 27071740
[TBL] [Abstract][Full Text] [Related]
25. A steady state system for in vitro evaluation of steroidogenic pathway dynamics: Application for CYP11B1, CYP11B2 and CYP17 inhibitors.
Mangelis A; Jühlen R; Dieterich P; Peitzsch M; Lenders JWM; Hahner S; Schirbel A; Eisenhofer G
J Steroid Biochem Mol Biol; 2019 Apr; 188():38-47. PubMed ID: 30529282
[TBL] [Abstract][Full Text] [Related]
26. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
[TBL] [Abstract][Full Text] [Related]
27. Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer.
Hu Q; Jagusch C; Hille UE; Haupenthal J; Hartmann RW
J Med Chem; 2010 Aug; 53(15):5749-58. PubMed ID: 20684610
[TBL] [Abstract][Full Text] [Related]
28. The potential of targeting CYP11B.
Bernhardt R
Expert Opin Ther Targets; 2016 Aug; 20(8):923-34. PubMed ID: 26854589
[TBL] [Abstract][Full Text] [Related]
29. Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human.
Cerny MA; Csengery A; Schmenk J; Frederick K
J Steroid Biochem Mol Biol; 2015 Nov; 154():197-205. PubMed ID: 26303746
[TBL] [Abstract][Full Text] [Related]
30. Potent 11β-hydroxylase inhibitors with inverse metabolic stability in human plasma and hepatic S9 fractions to promote wound healing.
Zhu W; Hu Q; Hanke N; van Koppen CJ; Hartmann RW
J Med Chem; 2014 Sep; 57(18):7811-7. PubMed ID: 25176013
[TBL] [Abstract][Full Text] [Related]
31. The discovery of potent inhibitors of aldosterone synthase that exhibit selectivity over 11-beta-hydroxylase.
Adams CM; Hu CW; Jeng AY; Karki R; Ksander G; Lasala D; Leung-Chu J; Liang G; Liu Q; Meredith E; Rao C; Rigel DF; Shi J; Smith S; Springer C; Zhang C
Bioorg Med Chem Lett; 2010 Aug; 20(15):4324-7. PubMed ID: 20615692
[TBL] [Abstract][Full Text] [Related]
32. CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets.
Hakki T; Bernhardt R
Pharmacol Ther; 2006 Jul; 111(1):27-52. PubMed ID: 16426683
[TBL] [Abstract][Full Text] [Related]
33. Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics.
Roumen L; Sanders MP; Pieterse K; Hilbers PA; Plate R; Custers E; de Gooyer M; Smits JF; Beugels I; Emmen J; Ottenheijm HC; Leysen D; Hermans JJ
J Comput Aided Mol Des; 2007 Aug; 21(8):455-71. PubMed ID: 17646925
[TBL] [Abstract][Full Text] [Related]
34. Aldosterone synthase inhibition in humans.
Azizi M; Amar L; Menard J
Nephrol Dial Transplant; 2013 Jan; 28(1):36-43. PubMed ID: 23045428
[TBL] [Abstract][Full Text] [Related]
35. Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
Pinto-Bazurco Mendieta MA; Hu Q; Engel M; Hartmann RW
J Med Chem; 2013 Aug; 56(15):6101-7. PubMed ID: 23859149
[TBL] [Abstract][Full Text] [Related]
36. Rhesus monkey model for concurrent analyses of in vivo selectivity, pharmacokinetics and pharmacodynamics of aldosterone synthase inhibitors.
Cai TQ; Stribling S; Tong X; Xu L; Wisniewski T; Fontenot JA; Struthers M; Akinsanya KO
J Pharmacol Toxicol Methods; 2015; 71():137-46. PubMed ID: 25304940
[TBL] [Abstract][Full Text] [Related]
37. Structure-based design of potent aromatase inhibitors by high-throughput docking.
Caporuscio F; Rastelli G; Imbriano C; Del Rio A
J Med Chem; 2011 Jun; 54(12):4006-17. PubMed ID: 21604760
[TBL] [Abstract][Full Text] [Related]
38. Functional maturation of the primate fetal adrenal in vivo: 3. Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis.
Coulter CL; Jaffe RB
Endocrinology; 1998 Dec; 139(12):5144-50. PubMed ID: 9832454
[TBL] [Abstract][Full Text] [Related]
39. Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase.
Fisher A; Friel EC; Bernhardt R; Gomez-Sanchez C; Connell JM; Fraser R; Davies E
J Clin Endocrinol Metab; 2001 Sep; 86(9):4326-9. PubMed ID: 11549669
[TBL] [Abstract][Full Text] [Related]
40. 1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.
Grombein CM; Hu Q; Heim R; Rau S; Zimmer C; Hartmann RW
Eur J Med Chem; 2015 Jan; 89():597-605. PubMed ID: 25462268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
